US equities
|
MU
$903.01
▲+2.75%
NVDA
$217.16
▲+1.42%
TSLA
$366.57
▲+3.34%
AMZN
$261.81
▲+4.72%
SNDK
$1,370.87
▲+5.51%
SPCX
$147.49
▲+1.00%
AMD
$537.25
▲+1.61%
META
$703.80
▼-0.78%
MU
$903.01
▲+2.75%
NVDA
$217.16
▲+1.42%
TSLA
$366.57
▲+3.34%
AMZN
$261.81
▲+4.72%
SNDK
$1,370.87
▲+5.51%
SPCX
$147.49
▲+1.00%
AMD
$537.25
▲+1.61%
META
$703.80
▼-0.78%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about MariTide
Recent news which mentions MariTide
Analyst Views Mixed As Amgen's Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues
June 24, 2025
Tickers
AMGN
NEWS
Tags
Health Care
Expert Ideas
Pharmaceutical
From
Benzinga
Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update
June 23, 2025
Tickers
AMGN
NEWS
Tags
Pharmaceutical
Health Care
AMGN
From
Benzinga
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
December 03, 2024
Tickers
AMGN
LLY
MRK
NVO
Tags
KeyProj
MariTide
MRK
From
Benzinga